Adjust Font Increase Font Decrease Font

The Catalyst

Yesterday, the New York Times’ Well blog posted a commentary on DTC advertising. Although its underlying tone was one of skepticism, it did briefly touch on a couple of useful points.

For example, the article noted: “It’s difficult to ascertain...

I think it’s great that billionaire David Rubenstein has decided to donate half the $15 million needed to repair the damage to the Washington Monument from the earthquake last year. While I’m no David Rubenstein, I do appreciate the importance of giving back to your community, as do my colleagues. The staff at PhRMA have been participating in St. Matthew’s Cathedral’s...

In his recent commentary, Merill Goozner of the Fiscal Times looks at the affordability of cancer medicines. Goozner rightly points out that the biopharmaceutical industry is continuing to invest heavily in new treatments for this disease. However,...

The Spotlight

Check out the George Washington University School of Medicine release 'Institute of Biomedical Sciences Student Awarded Two-Year Fellowship from PhRMA Foundation.' We're excited about this.

January 26 at 7:43pm